131 related articles for article (PubMed ID: 7006076)
21. Clinical experience in human diabetics with portable and implantable insulin minipumps.
Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ
Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370
[TBL] [Abstract][Full Text] [Related]
22. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
23. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
Tamborlane WV; Sherwin RS; Genel M; Felig P
Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
[TBL] [Abstract][Full Text] [Related]
24. Development of individual insulin infusion profiles for open loop infusion systems.
Strack T; Krause U; Schulz G; Beyer J; Beutelspacher F; Nagel J
Horm Metab Res; 1984 Apr; 16(4):163-7. PubMed ID: 6547110
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)].
Lambert AE; Buysschaert M; Van Halle B
Diabete Metab; 1979 Dec; 5(4):307-12. PubMed ID: 398299
[TBL] [Abstract][Full Text] [Related]
26. [Does the renal threshold change? Insulin therapy, based on urine glucose concentration, controlled by a dosage-measuring computer].
Hermányi I; Deutsoh T; Tamás G
Orv Hetil; 1989 Jun; 130(24):1269-72. PubMed ID: 2671856
[TBL] [Abstract][Full Text] [Related]
27. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
[TBL] [Abstract][Full Text] [Related]
28. [Anaesthesia and post-operative care in diabetic patients. Constant rate insulin infusion throughout surgery (author's transl)].
Edouard D; François P; Langlois B
Nouv Presse Med; 1980 Mar; 9(13):943-6. PubMed ID: 6987617
[TBL] [Abstract][Full Text] [Related]
29. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
Buysschaert M; Lejeune M; Lambert AE
Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
[TBL] [Abstract][Full Text] [Related]
30. [Progress and developments in insulin therapy].
Froesch ER; Blatter G; Candinas R; Süsstrunk H; Morell B
Schweiz Med Wochenschr; 1979 Dec; 109(46):1802-7. PubMed ID: 515716
[TBL] [Abstract][Full Text] [Related]
31. [When should stable maturity-onset diabetics be switched to insulin?].
Selz B; Nyffenegger U; Bürgi H
Schweiz Med Wochenschr; 1980 Oct; 110(42):1534-7. PubMed ID: 7006072
[TBL] [Abstract][Full Text] [Related]
32. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
[TBL] [Abstract][Full Text] [Related]
33. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
34. Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump.
Kølendorf K; Christiansen JS; Bojsen J; Svendsen PA; Teglbjaerg LL
Horm Metab Res; 1981 May; 13(5):245-9. PubMed ID: 7021384
[TBL] [Abstract][Full Text] [Related]
35. [Clinical use of insulin infusions using the open-loop system].
Irsigler K; Kritz H
Z Gesamte Inn Med; 1981 Jan; 36(1):8-19. PubMed ID: 7013294
[TBL] [Abstract][Full Text] [Related]
36. [Long-term treatment of diabetes with transplantation of a pancreatic segment].
Saudek F; Bartos V; Vanĕk I; Adamec M; Koznarová R; Sosna T; Boucek P; Vondrová H
Cas Lek Cesk; 1996 May; 135(11):348-53. PubMed ID: 8706071
[TBL] [Abstract][Full Text] [Related]
37. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
[No Abstract] [Full Text] [Related]
38. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
39. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
40. Insulin infusion via a portable pump.
Orzeck EA
Tex Med; 1980 Jul; 76(7):46-9. PubMed ID: 6994269
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
